Dr. Agarwal's IPO

Dr. Agarwal's IPO: Check IPO Date, Live Subscription and Key Details

Dr. Agarwal's Health Care Limited, started in 2010, provides a full range of eye care services, including cataract and refractive surgeries, consultations, non-surgical treatments, and the sale of optical goods, contact lenses, and eye medicines. By September 30, 2024, the company had 737 doctors, treated 2.13 million patients, and performed 220,523 surgeries. In the last six months, it treated 1.15 million patients and performed 140,787 surgeries.

Price Range
₹382.0 - ₹402.0
Issue Size
3,027.26 Cr
Lot Size
35 shares
IPO Type
Mainboard
GMP
-4(-1.00%)
Est. Listing Price
₹398
Estimate Profit
₹-140
Retail Portion
-
Face Value
₹1
EPS
2.51
P/E Ratio
160.48
RoNW
6.21%
ROE
9.33%
Advertisement

Timeline

IPO Opens

29 Jan

IPO Closes

31 Jan

Allotment

3 Feb

Listing

5 Feb

IPO Timeline & Listing Details

EventDate
IPO Open Date29 January 2025
IPO Close Date31 January 2025
Allotment Date3 February 2025
Listing Date5 February 2025

Investment Categories

CategoryLotsAmount
Retail (Min)
1₹14,070
Retail (Max)Just less than ₹2,00,000
14₹1,96,980
SHNI (Min)Just above ₹2,00,000
15₹2,11,050
SHNI (Max)Below ₹10,00,000
71₹9,98,970
BHNIAbove ₹10,00,000
72₹10,13,040

IPO Objectives

  • Repayment/prepayment, in part or full, of certain of the borrowings
  • General corporate purposes and unidentified inorganic acquisition.

Strengths

  • India’s largest eye care provider with a well-known and trusted brand.
  • Offers complete eye care services, catering to a wide variety of patients.
  • Efficient hub-and-spoke model that is scalable and asset-light.
  • Strong clinical expertise and a track record of surgical innovations.
  • Successful growth through expansion, acquisitions, and increased profitability.

Weaknesses

  • Limited reach in remote areas, making services less accessible to some people.
  • Faces strong competition from other leading eye care providers in India.
  • Relies heavily on skilled doctors to maintain service quality and performance.
  • High costs of advanced medical technology and treatments can be challenging.
  • Changes in healthcare regulations could affect flexibility and growth.
Advertisement

Financial Performance

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets (₹ Cr.)3,393.412,752.821,825.171,026.13
Revenue (₹ Cr.)837.941,376.451,031.49713.78
PAT (₹ Cr.)39.5695.05103.2343.16
Net Worth (₹ Cr.)1,502.671,337.68627.83212.34

Peer Comparison

CompanyP/B RatioP/E RatioRONW (%)Net Worth (₹ Cr.)
Dr. Agarwal's Health..8.04130.446.21%1,502.67
Apollo Hospitals13.2107.1162.5%7,321
Max Healthcare9.5295.8812.58%8,408

Subscription Details

Daily Bids Status

CategoryDay 1Day 2Day 3
QIB0x1.01x4.41x
NII0.06x0.12x0.39x
S-HNI0.09x0.2x0.54x
B-HNI0.04x0.08x0.29x
RII0.12x0.24x0.42x
EMP0.09x0.17x0.26x
Total0.07x0.42x1.49x

Overall Subscription Statistics

CategoryShares OfferedShares BidBid Amount (₹ Cr)
QIB1,45,19,2006,40,02,5752,572.9
NII1,08,89,40042,75,705171.88
Small NII36,29,80019,54,82078.58
Big NII72,59,60021,19,88085.22
RII2,54,08,5991,05,59,535424.49
EMP15,79,3994,18,11016.81
Total5,35,26,1727,98,30,1353,209.17
Advertisement

Company Details

  • Dr. Agarwal's Health Care Limited
  • 1st Floor, Buhari Towers No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006
  • +91 44 4378 7777
  • secretarial@dragarwal.com
  • https://dragarwals.co.in/

Registrar Details

Loading comments...